mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.8 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.3 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |